Form D · Pharmaceuticals

SAJE Pharma LLC

Baltimore, MD · CIK 0001549784

Offering snapshot reported May 15, 2012 · SEC filing

Reported sold: $50K
Investors reported: 1
Minimum accepted: $25K
First sale: May 3, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 15, 2012	Amendment	$50,000	$0vs May 11, 2012	1	SEC filing
May 11, 2012	Initial	$50,000	No comparison	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-178085

No one is receiving compensation for selling securities. We indicated Montana as a state of solicitation in Item 12, because we could not file the form without entering a state & MT is the only state in which SAJE Pharma, LLC has currently sold securities

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
none	None

Source: Form D, filed May 15, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Matthews O. Bradley	Executive
Helen S Pentikis	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

1101 E. 33 Rd Street Third Floor
Baltimore, MD, 21218